Ian Rabinowitz

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Neal Ready, Matthew D. Hellmann, Mark M. Awad et al. · Journal of Clinical Oncology · 2019 · 596 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Accuracy of radiation field alignment in clinical practice

Ian Rabinowitz, J Broomberg, Michael Goitein et al. · International Journal of Radiation Oncology*Biology*Physics · 1985 · 271 citations

Medicine, Radiation Oncology, Radiology +14

Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer

Massimo Cristofanilli, Vicente Valero, Aroop Mangalik et al. · Clinical Cancer Research · 2010 · 159 citations

Medicine, Oncology, Pharmacology +17

Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets.

Shaun P. Jackson, Simone M. Schoenwaelder, Yuping Yuan et al. · Journal of Biological Chemistry · 1994 · 127 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.

Anna M. Randi, Ian Rabinowitz, D J Mancuso et al. · Journal of Clinical Investigation · 1991 · 115 citations · Full text

Medicine, Genetics, Molecular Genetics +16